Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1182/blood.2020008092 http://scihub22266oqcxt.onion/10.1182/blood.2020008092 32882019!7472710!32882019     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32882019&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Blood 2020 ; 136 (10): 1115-1116 Nephropedia Template TP {{tp|p=32882019|t=2020. When CLL meets COVID-19 |pdf=|usr=}}{{32882019}} gab.com Text When CLL meets COVID-19 JO: Blood http://www.kidney.de/pget.php?&tw=1&pmid=32882019 #FOAvip In this issue of Blood, Mato et al report an international, multicenter analysis of 198 patients with chronic lymphocytic leukemia (CLL) and symptomatic COVID-19. In this analysis, COVID-19 appears to be more severe in CLL patients than in the general population and, although risk factors are the same as for the general COVID-19 population, the outcome of patients needing admission is poor, with a case fatality rate of 37%. The Mato et al paper is particularly compelling as reports of COVID-19 in specific diseases are needed, particularly in cancer where COVID-19 adds to the physical and emotional distress these patients already suffer. Also, clinicians need guidance on how to advise and manage these patients. Twit Text FOAVip When CLL meets COVID-19 ????Blood http://www.kidney.de/pget.php?&tw=1&pmid=32882019 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32882019 #FOAvip English Wikipedia <ref>{{Cite pmid|32882019}}</ref> When CLL meets COVID-19 #MMPMID32882019 Montserrat E Blood 2020[Sep]; 136 (10): 1115-1116 PMID32882019show ga In this issue of Blood, Mato et al report an international, multicenter analysis of 198 patients with chronic lymphocytic leukemia (CLL) and symptomatic COVID-19. In this analysis, COVID-19 appears to be more severe in CLL patients than in the general population and, although risk factors are the same as for the general COVID-19 population, the outcome of patients needing admission is poor, with a case fatality rate of 37%. The Mato et al paper is particularly compelling as reports of COVID-19 in specific diseases are needed, particularly in cancer where COVID-19 adds to the physical and emotional distress these patients already suffer. Also, clinicians need guidance on how to advise and manage these patients. |*Betacoronavirus[MESH] |*Coronavirus Infections[MESH] |*Leukemia, Lymphocytic, Chronic, B-Cell[MESH] |*Pandemics[MESH] |*Pneumonia, Viral[MESH] |COVID-19[MESH] |Humans[MESH]When CLL meets COVID-19 (epmc).pdf DeepDyve Pubget Overpricing